.About AstraZenecaAstraZeneca is a global, science-led, patient-focused biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines for some of the world's most serious diseases. We are more than one of the world's leading pharmaceutical companies.Oncology Research & Development, Late Development OncologyOur ambition is to eliminate cancer as a cause of death. It's our big vision that unites and inspires us. With multiple indications and high-quality molecules at all stages of our innovative pipeline, we keep pushing forward. Focusing on ground-breaking science with the latest technology to achieve breakthroughs. AZ is a place built on courage, curiosity and collaboration - we make bold decisions driven by patient outcomes. Late Development Oncology focuses on phase II - III clinical trials. Within Late Development Oncology, we push the boundaries of science to change the practice of medicine and transform the lives of patients living with cancer. With one of the broadest and deepest Oncology pipelines in the industry, there are many opportunities to work with new and novel drugs and help discover what's next. Supportive team players, we draw on diverse knowledge from across the business and external partners to come to bear on the toughest medical challenges.This position will focus on Lung Oncology.The Global Clinical Program Lead is accountable to the Global Clinical Head for a significant proportion of the Clinical Program, usually an indication-aligned cluster of clinical studies. This role is normally applied to portions of the Program that have a high degree of complexity based upon the known science or the size of the program, and/or due to a third-party collaboration that requires an incumbent to exercise greater expertise and judgement as well as to be effective in influencing and working across multifaceted partnerships. They will be required at times to deputize for the Global Clinical Head.You will work with the study physicians to support the design, conduct, monitoring and data interpretation of the studies to ensure that the clinical data collected within the studies will allow determination of the benefits and risks of the compound and meet the needs of the intended label indication and price in markets globally. You'll be expected to be strategic, generate opportunity and value for the asset or indication and be entrepreneurial to maintain a competitive advantage